✦ LIBER ✦

Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy

✍ Scribed by Choo, Richard; Lukka, Himu; Cheung, Patrick; Corbett, Tom; Briones-Urbina, Rosario; Vieth, Reinhold; Ehrlich, Lisa; Kiss, Alex; Danjoux, Cyril

Book ID: 123123667
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 255 KB
Volume: 85
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.11.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Controlled Trial of Zoledroni

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

✍ SMITH, MATTHEW R.; EASTHAM, JAMES; GLEASON, DONALD M.; SHASHA, DANIEL; TCHEKMEDY 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 106 KB

Re: Randomized Controlled Trial of Zoled

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 64 KB

Re: Randomized Controlled Trial of Zoled

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

✍ Pitts, W. Reid 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 57 KB

Risedronate for prevention of bone miner

Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial

✍ C. C. Mok; K. H. Tong; C. H. To; Y. P. Siu; K. M. Ma 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Double-blinded, Placebo-controlled Rando

Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy

✍ C. Choo; H. Lukka; A. Kiss; C. Danjoux 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

846 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-

846 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DENOSUMAB IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR NON-METASTATIC PROSTATE CANCER

✍ M.R. Smith; B. Egerdie; Toriz N. Hernández; R. Feldman; T.L.J. Tammela; F. Saad; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 504 KB